trastuzumab deruxtecan

Spain

Drugs containing this active substance

  • ENHERTU 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

    It is used to treat adults with HER2-positive breast cancer (metastatic or unresectable), breast cancer with low or very low HER2 expression, non-small cell lung cancer with an HER2 mutation, and HER2-positive stomach cancer.

    Form: powder for concentrate for solution for infusion

    Active substance Dosage
    trastuzumab deruxtecan 107 mg

    ATC: L01F L01FD L01FD04

    Manufacturer: Daiichi Sankyo Europe Gmbh